loading

Summit Therapeutics Inc (SMMT) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Operating Expenses
750.30%
568.44
66.85 65.82 58.11 59.78
Nonoperating Income/Loss
30.70%
2.729
3.938 13.10 2.124 -0.768
Income/Loss From Continuing Operations Before Tax
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Income/Loss From Continuing Operations After Tax
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Net Income/Loss
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.61%
742.62
738.08 6.3735 726.66 707.90
Diluted Average Shares
0.61%
742.62
738.08 6.3735 726.66 707.90
Basic Earnings Per Share
744.44%
-0.76
-0.09 -0.09 -0.08 -0.09
Diluted Earnings Per Share
744.44%
-0.76
-0.09 -0.09 -0.08 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$27.54
price up icon 0.53%
$85.73
price up icon 0.23%
$110.50
price up icon 7.16%
$143.53
price up icon 0.69%
biotechnology ONC
$337.66
price up icon 5.95%
大文字化:     |  ボリューム (24 時間):